Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander? (2012)

  • Authors:
  • USP affiliated authors: SANTOS FILHO, RAUL DIAS DOS - FM
  • USP Schools: FM
  • DOI: 10.1007%2Fs12020-012-9657-4
  • Subjects: OBESIDADE; ÁCIDO ÚRICO (NÍVEL;ANÁLISE); ARTERIOSCLEROSE; SÍNDROME X METABÓLICA; DOENÇAS CARDIOVASCULARES
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Endocrine
    • ISSN: 1355-008X
    • Volume/Número/Paginação/Ano: v. 41, n. 3, p. 350-352, 2012
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007%2Fs12020-012-9657-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007%2Fs12020-012-9657-4 (Fonte: Unpaywall API)

    Título do periódico: Endocrine

    ISSN: 1355-008X,1559-0100



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Endocrine

    ISSN: 1355-008X

    Citescore - 2017: 2.55

    SJR - 2017: 1.101

    SNIP - 2017: 0.95


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2345248-10BECEP 463 2012
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SANTOS, Raul D. Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander? Endocrine[S.l: s.n.], 2012.Disponível em: DOI: 10.1007%2Fs12020-012-9657-4.
    • APA

      Santos, R. D. (2012). Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander? Endocrine. Totowa. doi:10.1007%2Fs12020-012-9657-4
    • NLM

      Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander? [Internet]. Endocrine. 2012 ; 41( 3): 350-352.Available from: http://link.springer.com/content/pdf/10.1007%2Fs12020-012-9657-4.pdf
    • Vancouver

      Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander? [Internet]. Endocrine. 2012 ; 41( 3): 350-352.Available from: http://link.springer.com/content/pdf/10.1007%2Fs12020-012-9657-4.pdf

    Referências citadas na obra
    A.C. Gagliardi, M.H. Miname, R.D. Santos, Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202, 11–17 (2009)
    E.S. Ford, C. Li, S. Cook, H.K. Choi, Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115, 2526–2532 (2007)
    A.Q. Galvan, A. Natali, S. Baldi et al., Effect of insulin on uric acid excretion in humans. Am. J. Physiol. 268, E1–E5 (1995)
    U.M. Khosla, S. Zharikov, J.L. Finch et al., Hyperuricemia induces endothelial dysfunction and vasoconstriction. Kidney Int. 67, 1739–1742 (2005)
    G. Wu, C.J. Meininger, Nitric oxide and vascular insulin resistance. BioFactors 35, 21–27 (2009)
    F. Matsuura, S. Yamashita, T. Nakamura, M. Nishida, S. Nozaki, T. Funahashi, Y. Matsuzawa, Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47, 929–933 (1998)
    I. Fabregat, E. Revilla, A. Machado, Short-term control of the pentose phosphate cycle by insulin could be modulated by the NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem. Biophys. Res. Commun. 146, 920–925 (1987)
    T. Nakagawa, H. Hu, S. Zharikov, K.R. Tuttle, R.A. Short, O. Glushakova, X. Ouyang, D.I. Feig, E.R. Block, J. Herrera-Acosta, J.M. Patel, R.J. Johnson, A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 290, F625–F631 (2006)
    G. Reaven, Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Clin. Chem. 54, 785–787 (2008)
    K.L. Chien, M.F. Chen, H.C. Hsu, W.T. Chang, T.C. Su, Y.T. Lee, F.B. Hu, Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin. Chem. 54, 310–316 (2008)
    V. Bhole, J.W. Choi, S.W. Kim, M. de Vera, H. Choi, Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am. J. Med. 123, 957–961 (2010)
    T. Wang, Y. Bi, M. Xu, Y. Huang, Y. Xu, X. Li, W. Wang, G. Ning, Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40, 109–116 (2011)
    J.P. Gonçalves, A. Oliveira, M. Severo, A.C. Santos, C. Lopes, Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. (2012). Epub ahead of print
    M.Y. Desai, R.D. Santos, D. Dalal, J.A. Carvalho, D.R. Martin, J.A. Flynn, K. Nasir, R.S. Blumenthal, Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am. J. Cardiol. 95, 865–868 (2005)
    T. Yang, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, W.Y. Chou, K.L. Chien, L.C. Hwang, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220, 525–531 (2012)
    S.H. Boutcher, S.L. Dunn, T.E. Gail, J. Freund, Regional adiposity distribution and insulin resistance in young Chinese and European Australian women. Scand. J. Clin. Lab. Invest. 71, 653–657 (2011)
    R.D. Santos, Uric acid and cardiovascular disease: how to solve another chicken or egg puzzle. Cardiology 114, 298–299 (2009)
    C. Iribarren, A.R. Folsom, J.H. Eckfeldt, P.G. McGovern, F.J. Nieto, Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study. Atherosclerosis risk in communities. Ann. Epidemiol. 6, 331–340 (1996)
    R.D. Santos, K. Nasir, R. Orakzai, R.S. Meneghelo, J.A. Carvalho, R.S. Blumenthal, Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am. J. Cardiol. 99, 42–45 (2007)
    A.D. Liese, H.W. Hense, H. Löwel et al., Association of serum acid with all-cause and cardiovascular disease and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 10, 391–397 (1999)
    M.J. Bos, P.J. Koudstaal, A. Hofman, J.C.M. Witteman, M.M.B. Breteker, Uric acid is a risk factor for myocardial infarction and stroke. Stroke 37, 1503–1507 (2006)
    A. Strasak, E. Ruttmann, L. Brant et al., Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men. Clin. Chem. 54, 273–284 (2008)
    R.J. Johnson, D.H. Kang, D. Feig et al., Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 416, 1183–1190 (2003)
    F.J. Nieto, C. Iribarren, M.D. Gross, G.W. Cosmotock, R.G. Cutler, Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148, 131–139 (2000)